Loading clinical trials...
Loading clinical trials...
Effect of Cyproheptadine on Weight Gain and Feeding Behavior in 2 to 4 Years Old Children With Failure to Thrive
Cyproheptadine is currently clinically used as an appetite stimulant for children with failure to thrive without underlying organic disease. Otherwise, no randomised control trial demonstrates the efficacy of Cyproheptadine on those patients. This is precisely what the investigators intend to demonstrate on this randomised placebo control cross-over trial. Our hypothesis is that Cyproheptadine is more efficient than placebo to improve weight gain and feeding behaviour on 2 to 4 years old children with failure to thrive.
Age
2 - 4 years
Sex
ALL
Healthy Volunteers
No
Ste-Justine University Health Center
Montreal, Quebec, Canada
Start Date
December 1, 2010
Primary Completion Date
March 1, 2011
Completion Date
January 1, 2012
Last Updated
March 15, 2011
20
ESTIMATED participants
Cyproheptadine
DRUG
Sugar pill
DRUG
Lead Sponsor
St. Justine's Hospital
NCT07160387
NCT05333133
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions